Patrick W. Smith - 07 Feb 2025 Form 4 Insider Report for Oncocyte Corp (OCX)

Reporting relationship: 10%+ Owner
Issuer ticker: OCX
Reported as of: 07 Feb 2025
Net transaction value: +$2,999,999
SEC form: 4
Accepted by SEC: 11 Feb 2025, 17:00:15 UTC
Prior SEC filing: 04 Feb 2025
Next SEC filing: 26 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Patrick W. Smith

Key filing fact

Patrick W. Smith filed Form 4 for Oncocyte Corp (OCX) on 11 Feb 2025.

Key facts

This page summarizes Patrick W. Smith's Form 4 filing for Oncocyte Corp (OCX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Feb 2025, 17:00.

Change

Previous filing in this sequence was filed on 04 Feb 2025.
Current net transaction value: +$2,999,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OCX transaction

Common Stock, no par value

Purchase

Transaction value: $2,209,080
Shares: +1,077,600
Change %: +60%
Price: $2.05
Shares after: 2,872,671
Date: 07 Feb 2025
Ownership: See footnote
Footnotes: F1, F2

OCX transaction

Common Stock, no par value

Other

Transaction value: $790,919
Shares: +385,814
Change %: +13%
Price: $2.05
Shares after: 3,258,485
Date: 07 Feb 2025
Ownership: See footnote
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.

Footnote F2

The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.

Footnote F3

Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.